AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Results of a phase III clinical trial using Estrasorb released.(Brief Article)
2002 MAY 16 - (NewsRx.com & NewsRx.net) -- Novavax, Inc., (NVAX) presented the results of a randomized, double-blind, phase III, placebo-controlled clinical trial of Estrasorb in postmenopausal women at the Society for Gynecologic Investigation's 49th Annual Scientific Meeting.
Patients using Estrasorb (estradiol topical emulsion) experienced an 85% reduction in the total number of hot flashes during the course of the trial. The study also found that approximately half the patients reported complete cessation of hot flashes during a 7-day period by week 10 of treatment, while fewer than 10% of patients in the placebo group noticed a similar improvement in symptoms.
The study, which enrolled 200 women who were naturally or surgically menopausal, consisted of a 3-week screening period, a 1-week placebo period, and a 12-week treatment period. A 3-gram dose (approximately 1/2 teaspoon) of Estrasorb with 7.5 mg estradiol (100 patients) or placebo emulsion (100 patients) was applied daily to each thigh and calf. Hot flash data was collected and recorded in a patient diary.
...
- Novavax's Enters Final Phase of Its Commercial Launch of ESTRASORB(R).
- Press release article from: PR Newswire June 22, 2004 700+ words
...receiving their initial stocking orders for ESTRASORB. Novavax sales representatives are beginning full product...easy to fit into their daily routine." About ESTRASORB ESTRASORB is Novavax's first product utilizing its proprietary...
- Novavax to reacquire all rights to Estrasorb from King Pharmaceuticals.
- News wire article from: Asia Africa Intelligence Wire July 19, 2004 700+ words
...promotion agreement for Estrasorb (estradiol topical emulsion) enabling Novavax to reacquire all...marketing and promoting Estrasorb. In return, Novavax will pay King $22...worldwide rights to Estrasorb. Novavax anticipates the receipt...
- King Pharmaceuticals Announces Exclusive License for Estrasorb(TM) with Novavax.
- Press release article from: PR Newswire January 8, 2001 700+ words
...distribute and sell Estrasorb(TM), Novavax's topical, transdermal...territory. King and Novavax will co-market Estrasorb(TM) in the United...shall pay $5 million to Novavax if the NDA for Estrasorb(TM) is accepted for...
- Novavax's Launch of ESTRASORB(R) Underway.
- Press release article from: PR Newswire April 21, 2004 700+ words
...promotion to physicians. Novavax continues to receive encouraging feedback about ESTRASORB from both physicians...24,000 square foot ESTRASORB manufacturing and packaging...Philadelphia, Pennsylvania. ESTRASORB is Novavax's first product utilizing...
- Novavax and King Pharmaceuticals Announce FDA Approval of Estrasorb(TM); First...
- Press release article from: PR Newswire October 10, 2003 700+ words
...agents. With FDA approval of ESTRASORB, Novavax joins an elite group of biopharmaceutical...the marketing prospects for ESTRASORB." Novavax and King will co-promote...drugs." About ESTRASORB ESTRASORB employs Novavax's proprietary Micellar...
- Novavax to Reacquire All Rights to ESTRASORB(R) From King Pharmaceuticals.
- Press release article from: PR Newswire July 19, 2004 700+ words
...marketing and promoting ESTRASORB. In return, Novavax will pay King $22 million...the worldwide rights to ESTRASORB. Novavax anticipates the receipt...equipped to actively promote ESTRASORB." Novavax Investor Conference Call...
- Novavax, Inc. Clarifies Recent Form S-3 Registration Statement Filings and...
- Press release article from: PR Newswire August 18, 2004 700+ words
...connection with Novavax's repurchase...worldwide rights to ESTRASORB and related financings...23 million to Novavax's balance sheet to support the ESTRASORB launch and sales...In addition to ESTRASORB(R), Novavax has several product...
- Novavax's ESTRASORB Product Referenced on NBC's 'Today Show'.
- Press release article from: PR Newswire January 10, 2005 700+ words
Novavax, Inc. , a specialty pharmaceutical...Today" this morning referenced Novavax's ESTRASORB(R) product, a topical estrogen...including hormones. In addition to ESTRASORB(R), Novavax has several product candidates utilizing...
- FDA Accepts Novavax's New Drug Application for ESTRASORB(TM), a Topical...
- Press release article from: PR Newswire September 5, 2001 700+ words
...s U.S. co-promotion partner for ESTRASORB, Novavax has received a $2.5 million milestone...fund pre-launch marketing expenses for ESTRASORB. Novavax and King will co-promote ESTRASORB in the U.S. and Puerto Rico, while...
- Novavax Re-Acquires Rights to Estrasorb - Final.
- News wire article from: Fair Disclosure Wire July 19, 2004 700+ words
...agreement with King are now gone and ESTRASORB remains Novavax property regardless of any future relationships...ends the copromoted agreement between Novavax and King for ESTRASORB as well as ANDROSORB. Novavax also regains as I previously mentioned...
Source: HighBeam Research, Results of a phase III clinical trial using Estrasorb released.(Brief...